Clinical Trial Update: CFTR Modulators and Gastrointestinal Complications

View source ↗

Summary

A completed clinical trial evaluating CFTR modulator therapies and their gastrointestinal complications in cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Distal Intestinal Obstruction Syndrome
• Pancreatic Diseases

Drugs mentioned

• Kalydeco (ivacaftor)
• Symdeko (tezacaftor/ivacaftor)
• TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

Sponsor: Nottingham University Hospitals NHS Trust | Conditions: Cystic Fibrosis, Gastrointestinal System Disease | Status: COMPLETED